In a closed-door meeting at a Manhattan mansion, executives outlined changes to controversial software that was implicated in two crashes.Aerospace & Defenseread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
Minutes from the Reserve Bank of Australia's monetary policy meeting in July showed the central bank was ready to adjust interest rates if required.Asia Marketsread more
President Donald Trump and the RNC are picking up key supporters in the business community who did not back him as a candidate in 2016.2020 Electionsread more
Amazon workers in Minnesota and Germany are striking as Prime Day kicks off, in a stand against working conditions and wage practices. The action in Minnesota represents the...Retailread more
Treasury Secretary Steven Mnuchin is raising red flags ahead of Facebook's proposed cryptocurrency launch.Marketsread more
Epstein is accused of sexually exploiting dozens of underage girls from 2002 through 2005 at his New York and Florida residences. He is a former friend of Presidents Donald...Politicsread more
When you think of Prime Day, you might be thinking about deals on Instant Pots and Amazon Echo devices — not half-off dresses and designer heels. But the market for apparel...Retailread more
David Marcus, the head of Facebook's digital currency project, said the company expects Libra will drive more advertising revenue for the company.Technologyread more
Some White House officials expect the Cabinet secretary, who has known the president for years, to depart as soon as this summer.Politicsread more
"The important thing is that you shouldn't try to hit homeruns this week, because you're much more likely to end up striking out," Jim Cramer says.Mad Money with Jim Cramerread more
Strategist David Rosenberg named demographics the single most important factor for financial analysts and investors to monitor over the next decade.
"If it's all about 'follow the money,'" wrote Gluskin Sheff's Rosenberg, "then it is 'follow the boomers.'"
"Nothing is more important than this if you are looking at what will fundamentally influence the financial markets for the next decade-plus," he added.
The first of the baby boomers turned 70 this year, with another 1.5 million reaching that milestone each year for the next 15 years.
Crediting these demographic aging trends with the continued, "lower for longer theme" — lower growth, lower inflation and lower bond yields — Rosenberg noted that the markets' biggest surprise this year after the election of President Donald Trump was not the stock market.
Source: David Rosenberg, Gluskin Sheff
"It has clearly been the bond market, as the yield on the 10-year Treasury note, instead of breaking to or through the 3% threshold, never did come close and now resides south of 2.3%, " added Rosenberg.
"Aggregate growth in incomes and spending will be decelerating, and that will be posing additional deflationary pressures in the economy, and this in and of itself will ensure bond yields remain extremely low."
Rosenberg's research also found that as a cohort, boomers spend more on "experiences" like leisure, hospitality, recreation, entertainment and travel.
"As a share of income, those 65 and older actually dole out more on these services than the folks in the age groups behind them."
According to the latest Transamerica Retirement Survey, some 65 percent of baby boomers cited travel most often as their top dream for retirement, above spending more time with family or pursuing hobbies.
But to be sure, travel and hospitality aren't the only industries Rosenberg suggests investors eye as the U.S. population ages.
Biotech and medicine are positioned for continued growth as boomers consume more and more health care.
Spending on health care accounts for 16.6 percent of U.S. GDP, 5 percentage points more than Switzerland, the next closest country.
The iShares Nasdaq Biotechnology ETF (IBB) is up 23 percent year to date, hinting at strong growth in large pharmaceutical and other biotech companies in the coming years.